InKine Pharmaceutical Company Inc.

The best tips and advice from our vast library of articles, videos, and business tools

Tools

1-8 (of 8) related articles

Search Results

1-8 (of 8) related articles Sort by: Relevance \| Date Items per page
1. Inkine Pharmaceutical announces issuance of patents for Fc receptor... InKine Pharmaceutical Company, Inc. (Blue Bell, PA; 610-260-9364) announced that a United States patent has been issued to ... (PERIODICAL ARTICLE) 2. InKine changes pending NDA's brand name Worried that physicians and pharmacists would confuse an InKine Pharmaceutical NDA's brand name with an already approved sound-alike ... (PERIODICAL ARTICLE) 3. USING THE MARKET TO DETERMINE IP'S FAIR MARKET VALUE HEADNOTE New valuation methods can help CTOs carry out their mission of being "business scientists," extracting maximum cash ... (PERIODICAL ARTICLE) 4. FDA wants to be no.1 web site FDA wants to be No. 1 web site Add the FDA to the horde of web sites scuffling ... (PERIODICAL ARTICLE) 5. Nightly Business Report PAUL KANGAS, NIGHTLY BUSINESS REPORT ANCHOR: A major development from the Department of Agriculture late today, the discovery ... (PERIODICAL ARTICLE) 6. Nightly Business Report PAUL KANGAS, NIGHTLY BUSINESS REPORT ANCHOR: A major development from the Department of Agriculture late today, the discovery ... (PERIODICAL ARTICLE) 7. Concentrated announcements on clustered data: an event study on... In spring 2000, three events--two political statements by Bill Clinton and Tony Blair and a breakthrough announcement by ... (PERIODICAL ARTICLE) 8. MANUFACTURERS Celera Genomics Group has tapped Paulette Dillon as chief business officer. Dillon will lead strategic business and portfolio ... (PERIODICAL ARTICLE)
1-8 (of 8) related articles Sort by: Relevance \| Date Items per page 1-8 (of 8) related articles

Sponsored Links

Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.

Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.